Belgian Large Cap High Growth Potential

argenx

Market Cap: €34.5b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

D'Ieteren Group

Market Cap: €9.9b

Operates as an investment company in Belgium, France, rest of Europe, and internationally.

Elia Group

Market Cap: €10.8b

Develops and operates as a transmission system operator in Belgium and Germany.

Groupe Bruxelles Lambert

Market Cap: €9.3b

Invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally.

UCB

Market Cap: €37.1b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.